Journal of Clinical Bioinformatics is an open access, peer-reviewed online journal publishing original research on all aspects of the development of bioinformatics approaches, including tools, methodologies and data integration, for clinical and translational medicine.
JCBi aims to elucidate how biological and medical information can be applied to the development of personalized healthcare, medication and therapies. JCBi is a forum for the translation of bioinformatics and computational methods into clinical and medical applications, as well as the advancement of our understanding of the molecular and cellular mechanisms of diseases.
Editors-in-Chief
- Lance Liotta, George Mason University
- Xiangdong Wang, Fudan University Zhongshan Hospital
Society Affiliations
The Journal of Clinical Bioinformatics is affiliated with the International Society of Translational Medicine.Articles
-
Methodology
Journal of Clinical Bioinformatics 2012, 2:11 (1 May 2012)A dynamic model for tumour growth and metastasis formation
-
Research
Journal of Clinical Bioinformatics 2012, 2:10 (1 May 2012)A comparative analysis of protein targets of withdrawn cardiovascular drugs in human and mouse
-
Methodology
Journal of Clinical Bioinformatics 2012, 2:9 (16 April 2012)An eUtils toolset and its use for creating a pipeline to link genomics and proteomics analyses to domain-specific biomedical literature
-
Research
Journal of Clinical Bioinformatics 2012, 2:8 (3 April 2012)Functional repertoire, molecular pathways and diseases associated with 3D domain swapping in the human proteome
-
Review
Journal of Clinical Bioinformatics 2012, 2:7 (13 March 2012)Bioinformatics as a driver, not a passenger, of translational biomedical research: Perspectives from the 6th Benelux bioinformatics conference
-
Research
Journal of Clinical Bioinformatics 2012, 2:6 (12 March 2012)Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease
-
Research
Journal of Clinical Bioinformatics 2012, 2:5 (13 February 2012)Monte Carlo simulation of the Spearman-Kaerber TCID50
-
Research
Journal of Clinical Bioinformatics 2012, 2:4 (2 February 2012)Analysis of the salivary microbiome using culture-independent techniques
-
Research
Journal of Clinical Bioinformatics 2012, 2:3 (2 February 2012)A distinct metabolic signature predicts development of fasting plasma glucose
-
Short report
Journal of Clinical Bioinformatics 2012, 2:2 (1 February 2012)Brain cancer prognosis: independent validation of a clinical bioinformatics approach
- View more articles
Latest news
Latest Review
Journal of Clinical Bioinformatics 2012, 2:7 (13 March 2012)
Call for papers
Following the launch of the Pulmonary bioinformatics article series, JCBi is also now accepting submissions on the new series on Biomarkers in human disease. The call for papers highlights the key topics for the series and introduces the series co-Editors.
JCBi is also accepting submissions as part of an article collection on Cancer bioinformatics: Bioinformatic methods, network biomarkers and precision medicine. Jointly published across BMC Bioinformatics, BMC Cancer, Genome Medicine and Journal of Clinical Bioinformatics, submissions will be welcomed until 1st November 2012. Please see the call for papers for details including how to submit.
Society information
The International Society for Translational Medicine (ISTM) invite all JCBi scientists to become society members.
The International Society for Translational Medicine (ISTM) is a non-profit organization dedicated to communication and cross-fertilization among clinicians and researchers from all science fields with an interest in translational medicine. ISTM provides a platform to bring together clinicians, scientists and researchers from all biomedical fields, as well as providing a forum for interdisciplinary exchange of current knowledge and concepts on translational medicine through the society’s membership, professional development programs and conferences. ISTM accelerates the development and clinical application of new therapeutic strategies and diagnostic tools.
ISTM promotes the interaction and co-operation among physicians, scientists, researchers, policy makers, investors, business developers in academics, industries, funding agencies and governments. ISTM also provides professional recognition for engagement in translational medicine and promotes outstanding and innovative studies in the field of translational medicine. ISTM mainly focuses on cellular & molecular medicine, applied immunology, molecular imaging, regenerative medicine, drug discovery and development, biomaterials & clinical application, neurosciences, omics science, and oncology.
More information can be found at www.istmed.org.
Article series
-
Cancer bioinformatics: bioinformatic methods, network biomarkers and precision medicine
Edited by: Xiangdong Wang
Published: 1 May 2012
-
Biomarkers in human disease
Edited by: Prof Christian Baumgartner, Dr William CS Cho, Gerald Lushington, Prof Armin Graber, Dr Pablo Moscato, Dr Gregory Lewis
Published: 16 March 2012
Email updates
Receive periodic news and updates relating to this journal.
Indexed by
- CAS
- Google Scholar
- Index Copernicus
- PubMed
- PubMed Central
- Scopus